81 related articles for article (PubMed ID: 7475304)
1. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
Raes G; Geldhof A; Vanden Driessche T; Opdenakker G; Sibille C; De Baetselier P
Leukemia; 1995 Oct; 9 Suppl 1():S121-7. PubMed ID: 7475304
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
[TBL] [Abstract][Full Text] [Related]
4. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A
Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274
[TBL] [Abstract][Full Text] [Related]
5. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
6. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
Vanden Driessche T; Verschueren H; De Baetselier P
Invasion Metastasis; 1990; 10(2):65-85. PubMed ID: 2307562
[TBL] [Abstract][Full Text] [Related]
7. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
8. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
Mandelboim O; Feldman M; Eisenbach L
J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
[TBL] [Abstract][Full Text] [Related]
9. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
10. Novel regulation of an MHC class I gene response to interferon-gamma.
Schwarz DA; Buhlmann JE; Kuhne MR; Lam TM; White HD; Green WR
Cell Immunol; 1993 Aug; 150(1):90-100. PubMed ID: 7688271
[TBL] [Abstract][Full Text] [Related]
11. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
12. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression.
Esumi N; Hunt B; Itaya T; Frost P
Cancer Res; 1991 Feb; 51(4):1185-9. PubMed ID: 1900037
[TBL] [Abstract][Full Text] [Related]
13. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
14. Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.
Geldhof AB; Van Ginderachter J; Vandersteen P; Raes G; De Baetselier P
Clin Exp Metastasis; 1998 Jul; 16(5):447-59. PubMed ID: 10091940
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse gamma-interferon complementary DNA.
Nishihara K; Miyatake S; Sakata T; Yamashita J; Kikuchi H; Kawade Y; Zu Y; Namba Y; Hanaoka M; Watanabe Y
Cancer Res; 1988 Sep; 48(17):4730-5. PubMed ID: 3136912
[TBL] [Abstract][Full Text] [Related]
16. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
Burnham DK; Mak CK; Webster RJ; Daynes RA
Transplantation; 1989 Mar; 47(3):533-42. PubMed ID: 2493701
[TBL] [Abstract][Full Text] [Related]
17. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma.
Green WR; Phillips JD
J Immunol; 1986 Aug; 137(3):814-8. PubMed ID: 3088110
[TBL] [Abstract][Full Text] [Related]
18. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
19. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
Porgador A; Bannerji R; Watanabe Y; Feldman M; Gilboa E; Eisenbach L
J Immunol; 1993 Feb; 150(4):1458-70. PubMed ID: 8432988
[TBL] [Abstract][Full Text] [Related]
20. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
